Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

2005293 citationsJournal Article

Authors

Kayla F. Laserson · Centers for Disease Control and Prevention

Lorna E. Thorpe

Vaira Leimane · National Center for Tuberculosis and Lung Disease

Karin Weyer · South African Medical Research Council

Carole D. Mitnick · Harvard University Press

Vija Riekstiņa · National Center for Tuberculosis and Lung Disease

Evija Zarovska · National Center for Tuberculosis and Lung Disease

Abstract

Optimal management strategies for MDR-TB have not been evaluated in controlled clinical trials. Standardized definitions and cohort analyses will facilitate assessment and comparison of program performance. These data will contribute to the evidence base to inform decision makers on approaches to MDR-TB control.

Topics & Keywords

Tuberculosis Research and Epidemiology Pharmaceutical Economics and Policy Health Systems, Economic Evaluations, Quality of Life

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: PubMed

Volume 9, Issue 6, pp. 640-5

Field-Weighted Citation Impact: 6.91